Back to search

Article

Prognostic Role of Androgen Receptor Splice Variant 7 (AR-V7) in the Pathogenesis of Breast Cancer

2024-10-16

Abstract excerpt

<title>Abstract</title> <p>Background: The Androgen Receptor (AR) has emerged as an endocrine therapy target in Breast Cancer, exhibiting up to 80% expression in clinical cases. AR-V7, a constitutively activated splice variant of AR with a truncated ligand-binding domain (LBD), demonstrates ligand-independent transcriptional activity and resistance to nonsteroidal antiandrogens like Bicalutamide or Enzalutamide,...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ca2b5bad-675c-56ef-9e6f-a01da55ed0ac
DOI
10.21203/rs.3.rs-4959402/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Prognostic Role of Androgen Receptor Splice Variant 7 (AR-V7) in the Pathogenesis of Breast CancerDOI 10.21203/rs.3.rs-4959402/v1
Select a neighboring publication to make it the new centre.